Abstract

ABSTRACT

Thyroid cancer is the most frequent endocrine cancer worldwide. Early-stage thyroid cancer is commonly asymptomatic but can proceed to cause major symptoms like neck swelling which lead to difficulty in swallowing. Thyroid glands are necessary for hormone production and for managing multiple bodily processes but malfunctioning may lead to thyroid malignancy. Precise diagnosis, typically, the foundation of affective treatment and restoration of normal body functions. Focusing on radiopharmaceuticals, this review outlines the recent developments as well as the promising prospects for thyroid cancer diagnostics and treatment. In addition to enhancing patient’s treatment outcomes, the targeted diagnosis and medications makes possible more effective individualized treatment plans. Examining current advancements in radiopharmaceuticals that improve treatment efficacy and diagnostic accuracy, the review also addresses potential future prospects for this field of study and clinical practice.

Key words: Thyroid, radiopharmaceuticals, TSH, Thyroxin, SPECT/CT, Imaging.